Cancer Genetics Inc. (CGIX) Fell -5.13% or -0.04 To Price $0.65 On Thursday

Cancer Genetics Inc. (CGIX) fell -5.13% or -0.04 to $0.65. It is near 86207 shares traded, which is 63.24% compare to the average total volume 136307. The market cap of CGIX is $18.16 million. The year to date change is -69.75%. The 52 week price range is from $0.58 to $3.2. Price of CGIX have changed -9.82% during last week. It have changed -24.18% over last month, -30.94% over last 3 months, -24.17% over last 6 months and -78.44% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CGIX is 0.93. It is 43.08% above current price. The 200-day Moving Averages for CGIX is 1.17. It is 80.00% above current price. The 52-week High is 3.2. It is 392.31% from the current price. The 52-week Low is 0.58. It is -10.77% from current price.

There are some statistics of CGIX. It is has market cap $18.16 million. The share outstanding is 27.75 million. The average volume is 136307. The revenue is 8.03M. It has 4.81M cash and 7.93M in debt. The gross profit is 3.44M. The percent of top 15 Institution holding is 2.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CGIX is -91.52%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CGIX is -39.94%.


Share this post